CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Grant or award Director acquired 8,933 shares (grant or award)
- 4 Exercise or conversion Director acquired 9,469 shares (option exercise)
- 4 Open-market buy Director bought 15,000 shares at $3.05 ($45,750)
- 4 Open-market buy 10% owner bought 50,000 shares at an average $4.96 ($247,926)
- 4 Grant or award Chief Financial Officer acquired 55,556 shares (grant or award)
- 4 Grant or award General Counsel acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 50,000 shares (grant or award)
- 4 Grant or award President, Ophthalmology & CMO acquired 63,333 shares (grant or award)
- 4 Grant or award President and CEO acquired 186,750 shares (grant or award)
- 4 Open-market buy 10% owner bought 5,500 shares at $5.20 ($28,600)
- 4 Open-market buy 10% owner bought 74,500 shares at an average $5.45 ($405,808)
- 4 Open-market buy 10% owner bought 50,000 shares at an average $6.06 ($302,921)
- 4 Open-market buy 10% owner bought 44,490 shares at an average $6.35 ($282,421)
- 4 Open-market buy 10% owner bought 40,510 shares at an average $6.61 ($267,796)
- 4 Open-market buy 10% owner bought 60,900 shares at an average $6.18 ($376,603)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 5,000 shares at $9.89 ($49,450)
Page 9 of 18 · 354 filings